{
  "id": 15140270,
  "title": "Everpure CVO John Colgrove sells $14.5m in company stock",
  "url": "https://urgent.news/2026/10/17/everpure-cvo-john-colgrove-sells-14-5m-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-17T06:15:59.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/everpure-cvo-john-colgrove-sells-145m-in-company-stock-93CH-4955262"
  },
  "original_language": "en",
  "account": "John Colgrove, the Chief Visionary Officer and Director of Everpure Inc., sold 100,000 shares of the company's Class A Common Stock on October 14, 2026. The sale, facilitated by The Colgrove Family Charitable Remainder Trust, amounted to roughly $14.5 million. The shares were traded at prices between $141.31 and $153.68 per share, under a Rule 10b5-1 trading plan instituted on January 8, 2026. The stock had dropped nearly 20% over a week, reaching $124.01, but had increased by 85% over six months. InvestingPro analysis suggests the stock is trading near its Fair Value, with 18 more ProTips available to subscribers. Prior to these transactions, Colgrove had gifted 100,000 shares to the trust, which executed the sales. Post-transaction, Colgrove holds 5,393,309 shares directly and indirectly through various trusts: 467,694 shares in the Colgrove Family Living Trust, 2,415,000 shares in The EEC Irrevocable Trust, and 2,415,000 shares in The RWC Irrevocable Trust. The Colgrove Family Charitable Remainder Trust holds no shares post-sale. Additionally, Everpure Inc. announced a strong fiscal 2028 revenue outlook, projecting between $7.0 billion and $7.3 billion, marking a year-over-year growth of 39% to 45%. The company also expects non-GAAP operating income of $1.7 billion to $1.9 billion, indicating growth of 80% to 100% from previous years. Following these announcements, Needham raised Everpure's price target to $185 from $150, citing the company's growth story. Piper Sandler increased its target to $162 from $133, and Guggenheim raised it to $215 from $150, maintaining a Buy rating, due to insights from investor meetings and AI-infrastructure opportunities. These updates show analysts' increasing confidence in Everpure's future performance.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Everpure director Scott Dietzen sells $8.5m in company stock",
        "url": "https://urgent.news/2026/10/17/everpure-director-scott-dietzen-sells-8-5m-in-company-stock",
        "published": "2026-10-17T05:48:35.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}